11 sett 2017 anni - FDA held a Pediatric Advisory Committee meeting
to discuss the use of prescription opioid products
containing hydrocodone or codeine for the
treatment of cough in pediatric patients. The
discussion included current practice for the
treatment of cough in children and benefit-risk
considerations regarding the use of prescription
opioid products in pediatric patients.